Suboptimal medication adherence, a major problem among individuals with systemic lupus erythematosus, is often more pronounced among minority racial groups. As the roots of racial disparities in treatment adherence are beginning to be untangled, the need for multidisciplinary, multilevel approaches to tackle this complex problem is emerging.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lim, S. S. & Drenkard, C. Epidemiology of lupus: an update. Curr. Opin. Rheumatol. 27, 427–432 (2015).
Lim, S. S. et al. Racial disparities in mortality associated with systemic lupus erythematosus - Fulton and DeKalb counties, Georgia, 2002–2016. MMWR Morb. Mortal. Wkly Rep. 68, 419–422 (2019).
Rhew, E. Y. et al. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res. 153, 51–59 (2009).
Drenkard, C. & Lim, S. S. Update on lupus epidemiology: advancing health disparities research through the study of minority populations. Curr. Opin. Rheumatol. 31, 689–696 (2019).
Mehat, P. et al. Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res. 69, 1706–1713 (2017).
Sun, K. et al. Racial disparities in medication adherence between African American and Caucasian patients with systemic lupus erythematosus and their associated factors. ACR Open Rheumatol. 2, 430–437 (2020).
World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf (2003).
Feldman, C. H. et al. Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res. 67, 1712–1721 (2015).
Heiman, E. et al. Depressive symptoms are associated with low treatment adherence in African American individuals with systemic lupus erythematosus. J. Clin. Rheumatol. 24, 368–374 (2018).
Feldman, C. H. et al. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus. Semin. Arthritis Rheum. 48, 205–213 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Drenkard, C., Feldman, C.H. Untangling the complexity of medication adherence in SLE. Nat Rev Rheumatol 16, 605–606 (2020). https://doi.org/10.1038/s41584-020-0490-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0490-5